MIAMI--(BUSINESS WIRE)--Apr 7, 2026--
Petwealth, the at-home PCR diagnostics and AI-powered health intelligence platform for dogs and cats, today announced its emergence from stealth mode with $1.7 million raised to date and is currently raising its pre-seed round. The announcement comes as the U.S. pet industry has experienced a surge in growth over recent years, with Americans now spending more than $200 billion annually on their pets, a figure that reflects a fundamental shift in how people think about animal care. Petwealth is purpose-built to meet that moment, bringing clinical-grade diagnostics to a market that has long lacked them. Alongside this milestone, Petwealth unveiled two strategic partnerships: an exclusive diagnostic partnership with Kennel Connection and a telehealth integration with Pawp.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260406196969/en/
Founded in 2025 by Angelo Palivos following the sudden passing of his dog Mochi, Petwealth was built to do for pets what Function Health did for people, making clinical-grade health data proactive, personalized, and accessible before symptoms appear. Co-founder Zoë Barry joined shortly after founding, shaping the company's commercial strategy and vision for industry-wide impact. Palivos has also credited tech industry titan and investor Fareed Adib as a mentor instrumental to the company's strategic foundation.
“We are not just building a product. We are building the diagnostic infrastructure that the entire pet health industry has been missing. The partnerships we are announcing today are proof that the industry sees it too.”
- Angelo Palivos, Co-CEO and Co-Founder, Petwealth
The Platform
Petwealth operates an industry-best molecular laboratory processing thousands of tests per day. Its flagship product, The Petwealth Pack ($399), combines fecal, oral, and respiratory PCR panels into a single at-home kit with AI-powered health insights delivered in 24 to 48 hours. Individual panels are available at $175 each. The platform serves pet parents, veterinarians, and pet care businesses alike.
Kennel Connection: Exclusive Diagnostic Partner
Petwealth is the exclusive diagnostic partner for Kennel Connection, the leading pet care management software powering more than 5,500 locations across the U.S. The integration brings clinical-grade PCR screening directly into the daily operations of daycares, boarding facilities, groomers, and pet hotels.
“As the Pet Care Industry continues to grow, and more families cherish the lives of their fur babies, I believe it's our job to bring the most innovative and feature rich technology to the industry at large. After hearing Petwealth's story and seeing how this innovative Pet Health Technology is already saving pets lives, it was a no brainer for Kennel Connection to partner with Petwealth.”
- Jeff Brodsly, Owner and CEO, Kennel Connection
Pawp: Telehealth Partner
Through its partnership with Pawp, every Petwealth report connects pet parents to a licensed veterinarian on demand, 24/7, ensuring no one is left to interpret clinical results alone.
“At Pawp, we believe every pet parent deserves access to a veterinarian when it matters most. Partnering with Petwealth means that the moment a parent receives diagnostic results, they can connect with a licensed vet to understand what those results mean and what to do next. That closes a real gap in pet care.”
- Marc Atiyeh, CEO and Co-Founder, Pawp
About Petwealth
Petwealth is a Miami-based pet health diagnostics company founded in 2025 by Angelo Palivos and Zoë Barry. Born from the loss of Palivos' dog Mochi, the company delivers gold-standard PCR testing and AI-powered health insights for dogs and cats, screening 100+ markers across fecal, oral, and respiratory health with results in 24 to 48 hours. Petwealth's mission is to make proactive pet health simple, accessible, and trusted.
www.petwealth.com | press@petwealth.com | partnerships@petwealth.com
As pet care shifts toward prevention, Petwealth introduces a new category: at-home, clinical-grade diagnostics that translate complex biology into clear, actionable insights, with results delivered in under 48 hours.
